Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.
about
Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness modelOptimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical PracticeUse of antipsychotics in the treatment of depressive disordersMost antidepressant use in primary care is justified; results of the Netherlands Study of Depression and AnxietyExpenditures associated with dose titration at initiation of therapy in patients with major depressive disorder: a retrospective analysis of a large managed care claims database.Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.Diagnosis and management of depression in primary care: a clinical update and review.Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study.A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and PromisesMajor depression epidemiology from a diathesis-stress conceptualizationTreating bipolar disorder. Evidence-based guidelines for family medicine.Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.Bipolar spectrum disorders. New perspectivesA Web-based screening instrument for depression and anxiety disorders in primary care.Reboxetine: a preliminary report on its use through the Special Access ProgramMirtazapine for treatment-resistant depression: a preliminary report.What to do if an initial antidepressant fails?Can discrete event simulation be of use in modelling major depression?Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.What Are the Implications of the STAR*D Trial for Primary Care? A Review and SynthesisAntidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries.Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.A review of quetiapine in combination with antidepressant therapy in patients with depression.The use of driving impairing medicines: a European surveyThe clinical pharmacology of depressive states.Randomized controlled pilot trial of supportive text messages for patients with depression.Full remission: a return to normal functioning.Night eating model shows time-specific depression-like behavior in the forced swimming test.
P2860
Q21134108-D75450B4-E240-45ED-854A-0EAC53C9E46FQ26797416-D607C824-F4FD-49A1-9DB7-D7A90343E316Q26860391-E0D5A933-2166-41B3-932A-62DAC5A99332Q28477553-DDB1B3C7-596C-49EF-891B-5E87CCA4178EQ34111309-79883149-276C-4E47-9CF8-8FF8797D0C82Q34132596-603AB3C2-7FBC-4908-991C-3D070796EC1EQ34288455-543C4F17-1B3F-4006-8E6B-6A02C5020035Q34424124-5612F8F8-CB04-4F8D-88BD-BBF3FFDF923DQ34476432-0107EEF6-B0E2-488E-9A78-CAABED52E335Q34543797-2C62EB40-EB12-4911-859E-7D947DA80073Q34550254-5392A02E-526F-425D-A08A-1AC24EFBB960Q34644102-5E09994C-2392-438B-B811-82590F4EB661Q34675235-E28E41F2-B2BE-4013-8184-AFEFDEAD260AQ34998078-0A20BBD5-1C05-4947-B544-680A7897967DQ35101103-A11BAEFC-2412-4997-925F-F46DB4FEA78AQ35101425-C697CB92-BDE4-4E6C-A7E6-0682ECA8039CQ35120533-60DAD28E-D787-4D31-8317-28D2F5F71E88Q35568861-27BF370F-207C-4564-A604-DEBFB26F1DE3Q35601330-6CC83C73-71BA-4A3F-9753-F21990E256C3Q36538439-2243BF75-817D-482F-813D-54E14688511DQ36674976-11F13F96-8DB4-4360-AA2A-7DE8402868B8Q36731642-09237F48-8186-4E85-B2B8-58B4E77D82C8Q37129835-4752327D-4A7C-4E77-9D2B-D0A046B0F5DEQ37392543-DADF96E3-D699-46BF-AB52-DF15D29F531AQ38579133-82D8895D-B60B-4679-9E94-EDFD6053B0DAQ38646265-5E5855DB-3B63-481C-94FE-EC2F19C891B4Q39775490-3011907E-84BF-46B7-A3A3-62107D16749EQ47652156-8B9D9BBD-E453-4DA0-A0F5-25EFBD5FD17C
P2860
Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical guidelines for the tr ...... d other biological treatments.
@ast
Clinical guidelines for the tr ...... d other biological treatments.
@en
Clinical guidelines for the tr ...... d other biological treatments.
@nl
type
label
Clinical guidelines for the tr ...... d other biological treatments.
@ast
Clinical guidelines for the tr ...... d other biological treatments.
@en
Clinical guidelines for the tr ...... d other biological treatments.
@nl
prefLabel
Clinical guidelines for the tr ...... d other biological treatments.
@ast
Clinical guidelines for the tr ...... d other biological treatments.
@en
Clinical guidelines for the tr ...... d other biological treatments.
@nl
P2093
P1476
Clinical guidelines for the tr ...... nd other biological treatments
@en
P2093
A V Ravindran
CANMAT Depression Work Group
S H Kennedy
P304
P407
P478
46 Suppl 1
P577
2001-06-01T00:00:00Z